Symbol="VERA"
AssetType="Common Stock"
Name="Vera Therapeutics Inc"
Description="Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases in the United States. The company is headquartered in South San Francisco, California."
CIK="1831828"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="170 HARBOR WAY, 3RD FLOOR, SOUTH SAN FRANCISCO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="750668000"
EBITDA="-90727000"
PERatio="None"
PEGRatio="None"
BookValue="3.563"
DividendPerShare="0"
DividendYield="0"
EPS="-3.43"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.351"
ReturnOnEquityTTM="-0.699"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-3.43"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="14.6"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.309"
EVToRevenue="-"
EVToEBITDA="-4.858"
Beta="0.286"
num_52WeekHigh="23.39"
num_52WeekLow="5.2"
num_50DayMovingAverage="12.18"
num_200DayMovingAverage="11.97"
SharesOutstanding="44261100"
DividendDate="None"
ExDividendDate="None"
symbol="VERA"
open="16.51"
high="17.14"
low="16.50"
price="16.96"
volume="363133.00"
latest_trading_day="2023-07-20"
previous_close="16.59"
change="0.37"
change_percent="2.2303%"
aroon_positive_momentum_days="43"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Trending Low"
value_analysis="Bearish Trend"
Aroon_change="FALSE"
Aroon_momentum="43"
Volume_recent_avg="598712"
Change_recent_avg="0.05"
Delta_recent_avg="0.71"
Variance_recent_avg="0.35"
Change_ratio_recent_avg="0.32"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="43"
Aroon_momentum_negative="57"
image_negative_thumbnail_id_1="1149"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0182.jpeg"
image_negative_thumbnail_id_2="94"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0082.jpeg"
image_neutral_thumbnail_id_1="570"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_neutral_thumbnail_id_2="540"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_positive_thumbnail_id_1="703"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0005.jpeg"
image_positive_thumbnail_id_2="705"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0003.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
